Finally, although our results indicated that MAP3K14 rs2074292 played an important role in HBV-HCC survival and may serve as a potential therapeutic target for HBV-HCC, more experiments will need to performed to fully understand the underlying molecular mechanisms of MAP3K14 rs2074292 in future studies. Here, MAP3K14 is linked to hepatocellular carcinoma.